Literature DB >> 17537652

Our cells get stressed too! Implications for human disease.

Michael B Kastan1.   

Abstract

Significant progress has been made in recent years elucidating the molecular controls of cellular responses to DNA damage in mammalian cells. Many of the insights that we have gained into the mechanisms involved in cellular DNA damage response pathways have come from studies of human cancer susceptibility syndromes that are altered in DNA damage responses. ATM, the gene mutated in the cancer-prone disorder, ataxia telangiectasia, is a protein kinase that is a central mediator of responses to DNA double strand breaks in cells. Such insights provide us with opportunities to develop new approaches to benefit patients. For example, inhibitors of the ATM pathway have the potential to act as sensitizers to chemotherapy or radiation therapy and could even have anti-neoplastic effects on their own. Conversely, activators of ATM could improve responses to cellular stresses such as oxidative damage. The potential benefits of ATM modulation in disease settings ranging from metabolic syndrome to cancer will be discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537652      PMCID: PMC1989115          DOI: 10.1016/j.bcmd.2007.04.002

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  20 in total

1.  Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.

Authors:  B Xu; M B Kastan
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.

Authors:  Byoung-Il Bae; Hong Xu; Shuichi Igarashi; Masahiro Fujimuro; Nishant Agrawal; Yoichi Taya; S Diane Hayward; Timothy H Moran; Craig Montell; Christopher A Ross; Solomon H Snyder; Akira Sawa
Journal:  Neuron       Date:  2005-07-07       Impact factor: 17.173

Review 3.  ATM: genome stability, neuronal development, and cancer cross paths.

Authors:  Y Shiloh; M B Kastan
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

4.  Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.

Authors:  D Q Yang; M B Kastan
Journal:  Nat Cell Biol       Date:  2000-12       Impact factor: 28.824

5.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.

Authors:  D S Lim; S T Kim; B Xu; R S Maser; J Lin; J H Petrini; M B Kastan
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

7.  ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome.

Authors:  Jochen G Schneider; Brian N Finck; Jie Ren; Kara N Standley; Masatoshi Takagi; Kirsteen H Maclean; Carlos Bernal-Mizrachi; Anthony J Muslin; Michael B Kastan; Clay F Semenkovich
Journal:  Cell Metab       Date:  2006-11       Impact factor: 27.287

8.  Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.

Authors:  John Mercer; Nichola Figg; Victoria Stoneman; Denise Braganza; Martin R Bennett
Journal:  Circ Res       Date:  2005-03-03       Impact factor: 17.367

9.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.

Authors:  Helen E Bryant; Niklas Schultz; Huw D Thomas; Kayan M Parker; Dan Flower; Elena Lopez; Suzanne Kyle; Mark Meuth; Nicola J Curtin; Thomas Helleday
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

10.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors:  Hannah Farmer; Nuala McCabe; Christopher J Lord; Andrew N J Tutt; Damian A Johnson; Tobias B Richardson; Manuela Santarosa; Krystyna J Dillon; Ian Hickson; Charlotte Knights; Niall M B Martin; Stephen P Jackson; Graeme C M Smith; Alan Ashworth
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

View more
  5 in total

1.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

Review 2.  Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy.

Authors:  Sanjeev Shangary; Shaomeng Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

Review 3.  Biotests and Biosensors for Ecotoxicology of Metal Oxide Nanoparticles: A Minireview.

Authors:  Anne Kahru; Henri-Charles Dubourguier; Irina Blinova; Angela Ivask; Kaja Kasemets
Journal:  Sensors (Basel)       Date:  2008-08-28       Impact factor: 3.576

Review 4.  Multifunctional role of ATM/Tel1 kinase in genome stability: from the DNA damage response to telomere maintenance.

Authors:  Enea Gino Di Domenico; Elena Romano; Paola Del Porto; Fiorentina Ascenzioni
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

Review 5.  Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus.

Authors:  Enea Gino Di Domenico; Luigi Toma; Valentina Bordignon; Elisabetta Trento; Giovanna D'Agosto; Paola Cordiali-Fei; Fabrizio Ensoli
Journal:  Int J Mol Sci       Date:  2016-06-01       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.